Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kidney/Urinary Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT04731376
What this trial is testing

Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone

Who this might be right for
HypogonadismMalignant Urinary System NeoplasmUrinary System Disorder+1 more
Emory University 56
Testing effectiveness (Phase 2)Ended earlyNCT04383210
What this trial is testing

Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

Who this might be right for
Locally Advanced Solid TumorMetastatic Solid TumorPancreatic Cancer+14 more
Elevation Oncology 54
Early research (Phase 1)Study completedNCT02619253
What this trial is testing

Phase I/Ib Study of Pembrolizumab With Vorinostat for Patients With Advanced Renal or Urothelial Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaUrinary Bladder Neoplasms
Nabil Adra 52
Testing effectiveness (Phase 2)Ended earlyNCT03397394
What this trial is testing

Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Who this might be right for
Bladder CancerUrothelial CarcinomaMetastatic Urothelial Carcinoma+5 more
pharmaand GmbH 97
Testing effectiveness (Phase 2)Looking for participantsNCT06983210
What this trial is testing

Clinical Trial of AM80 in Combination With Gemcitabine, Cisplatin, and Nivolumab in Patients With Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma BladderUrothelial Carcinoma of the Renal Pelvis and UreterUrothelial Carcinoma Urethra+1 more
Nagoya University 43
Testing effectiveness (Phase 2)Ended earlyNCT03637803
What this trial is testing

Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors

Who this might be right for
OncologySolid TumorNon Small Cell Lung Cancer+3 more
4D pharma plc 63
Not applicableStudy completedNCT01614808
What this trial is testing

Studying Biomarkers in Urine Samples From Younger Patients With Wilms Tumor

Who this might be right for
Recurrent Wilms Tumor and Other Childhood Kidney TumorsStage III Wilms Tumor
Children's Oncology Group 90
Not applicableLooking for participantsNCT07037589
What this trial is testing

Women With isoLated acUte cyStitis and Macroscopic Hematuria. Is Further Investigation Needed?

Who this might be right for
HematuriaAcute Cystitis With HematuriaBladder Cancer+2 more
Vastra Gotaland Region 300
Not applicableLooking for participantsNCT06287541
What this trial is testing

The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral Resection

Who this might be right for
Non Muscle Invasive Bladder Cancer
The First Affiliated Hospital with Nanjing Medical University 428
Not applicableStudy completedNCT06087016
What this trial is testing

Urinary Markers by SpectrosCopy: Diagnostic Aid in oncologY - Application to Urological Cancers

Who this might be right for
Urinary Bladder Tumour
CHU de Reims 899
Not applicableEnrolling By InvitationNCT02609269
What this trial is testing

Decipher Genomics Resource for Intelligent Discovery

Who this might be right for
Prostate CancerBladder CancerRenal Cancer
GenomeDx Biosciences Corp 1,000,000
Early research (Phase 1)Looking for participantsNCT06242470
What this trial is testing

MGC026 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorAdvanced CancerMetastatic Cancer+19 more
MacroGenics 250
Not applicableLooking for participantsNCT06397287
What this trial is testing

PROM Project Urology

Who this might be right for
SurgeryUrologic DiseasesUrologic Cancer
Medical University of Graz 47
Testing effectiveness (Phase 2)Looking for participantsNCT07828704
What this trial is testing

Photodynamic Diagnosis of Kidney Cancer Using Fluorescence Endoscopy and Oral 5-ALA

Who this might be right for
Kidney Cancers
Henry Ford Health System 10
Not applicableStudy completedNCT03548688
What this trial is testing

Investigation and Detection of Urological Neoplasia in Patients Referred With Suspected Urinary Tract Cancer:

Who this might be right for
Urothelial Carcinoma
British Urology Researchers in Surgical Training 11,059
Not applicableStudy completedNCT00253383
What this trial is testing

Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients

Who this might be right for
Cancer
Dartmouth-Hitchcock Medical Center 329
Not applicableStudy completedNCT05461430
What this trial is testing

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

Who this might be right for
Pleural Effusion, MalignantAscites, MalignantCarcinoma+29 more
Travera Inc 72
Early research (Phase 1)Study completedNCT03454451
What this trial is testing

CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers

Who this might be right for
Non-Small Cell Lung CancerRenal Cell CancerColorectal Cancer+10 more
Corvus Pharmaceuticals, Inc. 117
Early research (Phase 1)Active Not RecruitingNCT05393427
What this trial is testing

BL-B01D1 in Patients With Locally Advanced or Metastatic Urological Tumors and Other Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Urinary TumorsOther Solid Tumors
Sichuan Baili Pharmaceutical Co., Ltd. 4
Not applicableStudy completedNCT00216801
What this trial is testing

Relationship of Ochratoxin A to Upper Urologic Cancers

Who this might be right for
Transitional Cell CarcinomaRenal Cell CancerTesticular Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 60
Next Page